Format

Send to

Choose Destination
Nat Rev Drug Discov. 2016 Apr;15(4):217-8. doi: 10.1038/nrd.2016.33.

Putting translational science on to a global stage.

Author information

1
National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20817, USA.
2
Alzheon Inc., Framingham, Massachusetts 01701, USA; and EATRIS ERIC, European Infrastructure for Translational Medicine, Amsterdam 1081 HZ, Netherlands.
3
MRC Technology, London WC1H 9LT, UK.
4
Therapeutic Innovation Australia, Melbourne, Victoria 2000, Australia.
5
Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic; and EATRIS ERIC, European Infrastructure for Translational Medicine, Amsterdam 1081 HZ, Netherlands.
6
EATRIS ERIC, European Infrastructure for Translational Medicine, Amsterdam 1081 HZ, Netherlands.
7
The Centre for Drug Research and Development, Vancouver, British Columbia V6T 1Z3, Canada.

Abstract

Global collaboration in translational science promises to accelerate the discovery, development and dissemination of new medical interventions. Here, we introduce a new international collaboration of translational science organizations and highlight our initial strategy to reduce or remove bottlenecks in translation.

PMID:
27032820
PMCID:
PMC5378162
DOI:
10.1038/nrd.2016.33
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center